Search

In order to preserve healthcare resources and provide exceptional care, our teams have been working together to develop new and innovative ways to treat our patients during the COVID-19 pandemic. MSK radiation oncologists rapidly re-evaluated our rectal cancer practice policies during this public health emergency.

… Friday, May 15, 2020 Cancer care is essential and should not be put on hold. Here at Memorial Sloan Kettering (MSK) we’ve put in place the strictest safety measures to ensure our patients continue to receive world-class cancer care in the safest environment possible. In order to preserve healthcare resources

Spinal cord compression due to spinal metastases is a medical emergency. Modern treatment approaches have fundamentally shifted the paradigm from providing short-term palliation and pain relief to delivering durable tumor control with fewer morbidities than older approaches. Therefore, cancer patients who have symptoms of spinal cord compression should be referred for surgical evaluation as soon as possible.

… Thursday, June 14, 2018 Spinal cord compression due to spinal metastases is a medical emergency. Modern treatment approaches — minimally invasive surgical techniques and spinal stereotactic radiosurgery (SSRS) — have fundamentally shifted the paradigm from providing short-term palliation and pain relief

The test, developed at MSK, looks for alterations in 468 genes that are seen in both common and rare cancers.

… Wednesday, November 15, 2017 Summary The FDA’s authorization of MSK-IMPACT sets a precedent for future authorization of tests developed by both academic and commercial labs. The US Food and Drug Administration has announced the authorization of MSK-IMPACT™ . The test was developed by Memorial Sloan Kettering

Originally explored as a cancer drug, the tree-derived chemical is now being mined for its antiviral properties.

… Monday, February 8, 2021 Summary Researchers at Memorial Sloan Kettering in collaboration with scientists in Germany have discovered that an investigational cancer drug has powerful effects against SARS-CoV-2, the virus that causes COVID-19. An investigational cancer drug with roots in the Malaysian

Memorial Sloan Kettering scientists have engineered a tiny particle that could ferry drugs directly to the kidneys and prevent their uptake in other organs.

… Monday, June 8, 2015 Summary Ideas abound about how to develop smarter cancer drugs with the help of nanotechnology , using tiny materials with unusual chemical and physical properties. For renal cell carcinoma (RCC), a common form of kidney cancer , a new nanoparticle could make it possible to deliver

Learn how acupuncture is being used at the MSK Ralph Lauren Center in Harlem to reduce pain and other symptoms in people facing cancer.

… Thursday, January 29, 2026 This story was originally published in 2024 and has been updated with results from a study of the Ralph Lauren Integrative Medicine program published in JCO Oncology Practice.  Elizabeth Sosa knew she was in good hands when Charles Rico suggested acupuncture to help reduce

Memorial Sloan Kettering Cancer Center introduced a new, consumer-friendly web presence for www.mskcc.org (Memorial Sloan Kettering Cancer Center) and www.sloankettering.edu (Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center), featuring an innovative platform and on-demand navigation for patients, caregivers, researchers, healthcare professionals, and graduate students, among other core audiences.

… Tuesday, May 5, 2015 Memorial Sloan Kettering Cancer Center (MSK) introduced a new, consumer-friendly web presence for www.mskcc.org (Memorial Sloan Kettering Cancer Center) and www.sloankettering.edu (Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center

Learn how computational biology and advances in artificial intelligence at MSK are improving cancer care from immunotherapy and radiation treatments to diagnostic scans and tests.

… Monday, June 10, 2024 The microscope. The petri dish. The X-ray. A handful of tools have radically changed the practice of medicine and biomedical research. Although easy to overlook, the computer microchip, with its layers of silicon and engineering wizardry, is without a doubt one of the most important

New data from researchers at MSK featured in the 2022 ASCO Annual Meeting press program and simultaneously published in The New England Journal of Medicine highlights a novel antibody-drug conjugate that doubled progression-free survival in HER2-low metastatic breast cancer.

… Sunday, June 5, 2022 Update: On August 5, 2022, the FDA approved the first targeted therapy for patients with HER2-low  breast cancer  that has spread to other parts of the body and is unable to be surgically removed. The drug,  https://www.mskcc.org/cancer-care/patient-education/fam-trastuzumab-deruxtecan

Seven students will be awarded PhD degrees on May 19, 2021, from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK), an innovative doctoral program that prepares the next generation of basic laboratory scientists to work in research areas related to human disease with a focus on cancer.

… Monday, May 17, 2021 Seven students will be awarded PhD degrees on May 19, 2021, from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) , an innovative doctoral program that prepares the next generation of basic laboratory scientists to work in research areas related to human